Department of Interventional Radiology, Memorial Sloan-Kettering Cancer Center, 1275 York Ave, Rm H118, New York, NY 10065, USA.
AJR Am J Roentgenol. 2011 Oct;197(4):W581-9. doi: 10.2214/AJR.11.7536.
Surgical resection remains the treatment of choice for patients with early-stage primary lung cancer and selected patients with limited metastatic lung disease. However, surgery is a high-risk treatment for patients with coexisting morbidities, severe chronic obstructive pulmonary disease, a single lung, or a history of prior resection. The indications for and outcomes of ablative therapies performed for the management of pulmonary malignancies are discussed.
Preservation of residual lung parenchyma when treating patients with early-stage primary lung cancer and those with limited metastatic lung disease is vital and can be achieved with image-guided thermal ablation therapies.
手术切除仍然是早期原发性肺癌和选定的有限转移性肺部疾病患者的首选治疗方法。然而，对于合并多种疾病、严重慢性阻塞性肺疾病、单肺或既往切除史的患者，手术是一种高风险的治疗方法。本文讨论了用于治疗肺部恶性肿瘤的消融治疗的适应证和结果。
对于治疗早期原发性肺癌患者和有限转移性肺部疾病患者，保留残余肺实质至关重要，可通过图像引导的热消融治疗来实现。
